Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
MiNK Therapeutics
(6Q40.F) Q2 2026
Earnings
6Q40.F
May 15
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.91
-0.76
-0.62
-0.47
Details
Expected EPS
-0.6623463
Actual EPS
-0.4903083
Surprise EPS
0.17
Surprise Percent
+25.97%
Description
MiNK Therapeutics (6Q40.F) has reported earnings of -0.4903083 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login